S&P 500
7,615.40
-0.09%
Dow Jones
51,327.00
-0.09%
Nasdaq 100
30,644.80
-0.23%
Russell 2000
2,928.08
-0.17%
FTSE 100
10,381.30
-0.06%
Nikkei 225
68,144.20
+0.95%

Health and Healthcare

CryoCor Regains Lost Ground; FDA Remains Unpredictable (CRYO)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published

CryoCor Inc. (CRYO-NASDAQ) is trading up almost 100% in early trading today.  Last night the company announced that an FDA Advisory Panel had recommended backing the company’s pre-market approval application for the company’s treatment device for atrial flutter (ahead of the formal vote in August).

Back on June 25, all the way back to Monday, this stock took a beating.  The FDA had posted its review stating that the device that uses extreme cold to treat defective heart muscle did not show overwhelmingly safe or effective results in company studies.  Shares fell from $4.40 down to $2.77 at the close on Monday.  Now shares are back up to $4.95.

This just goes to show how volatile and unpredictable the FDA can be.  If you don’t believe that the FDA is becoming more and more unpredictable, go ask a certain maker of a last line of defense for prostate cancer about it.  CryoCor has a 52-week trading range of $1.25 to $7.35, and its market cap based on a $4.95 price is only $60 Million.

Jon C. Ogg
June 28, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Follow 24/7 Wall St. on Google
Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Douglas A. McIntyre |

CryoCor (CRYO): Another Small Med Company Rallies Like Mad

CryoCor (CRYO) had revenue of $540,000 last year, and a loss of over $15 million. It did not do much…

Paul Ausick |

Midday Meme Stock Report for 7/12: AMC, Meta Materials, Newegg, Virgin Galactic

At the noon hour Monday, three meme stocks were trading down by double-digit percentages.

Jon C. Ogg |

RF Micro, From Bad To Worse (RFMD)

RF Micro Devices Inc. (NASDAQ: RFMD) was down a lot last night but shares are getting spanked even harder now. …

Midday Meme Stock Report for 8/9: AMC, Clover Health, DraftKings, Meta Materials
Paul Ausick |

Midday Meme Stock Report for 8/9: AMC, Clover Health, DraftKings, Meta Materials

AMC shares were putting on a little weight as investors wait to see the company's second-quarter earnings report. And Meta…

Jon C. Ogg |

Will Prana’s Implosion Go All the Way?

ThinkstockThe first question anyone might ask if a stock falls from more than $9 to less than $2.50 is whether…

QEP Resources Prices Secondary Offering
Chris Lange |

QEP Resources Prices Secondary Offering

QEP Resources saw its shares move down handily on Monday following the pricing of its secondary offering.

Douglas A. McIntyre |

Does Palm Deserve Its Tenfold Rise? (PALM, AAPL, RIMM)

Palm, Inc. (NASDAQ: PALM) has been on a tear of late.  It was just Monday that shares were hitting fresh…

Paul Ausick |

Will the End of Fitbit Quiet Period Give the Stock a Jolt?

The 25-day quiet period on Fitbit ends Monday, and we can expect to see the company’s underwriters pushing out analysis…

Lee Jackson |

5 Very Oversold Tech Stocks Could Be Huge Buys Now

A new research report from the Information Technology and Hardware analysts at UBS tracks the stocks that are the most…

Top Gaining Stocks

Hewlett Packard Enterprise
HPE • Vol: 153,197,465
Enphase Energy
ENPH • Vol: 8,360,053
Corning
GLW • Vol: 18,152,646
Alexandria Real Estate Equities
ARE • Vol: 4,337,015
Aptiv
APTV • Vol: 6,761,325

Top Losing Stocks

Trade Desk
TTD • Vol: 21,905,513
Intuit
INTU • Vol: 7,383,018
Coterra Energy
CTRA • Vol: 73,319,495
Cboe Global Markets
CBOE • Vol: 5,000,011
HP
HPQ • Vol: 29,259,826